So Johnson & Johnson & the blood clots, how bad is it?
- Johnson & Johnson takes up only 5% of the vaccination given to people so far, so even a pause on Johnson & Johnson likely won’t affect the vaccination rollout much.
- The chance of getting blood clots from the J&J vaccine is somewhat equivalent to the chance of getting struck by lightning.
- Johnson & Johnson is not a bad vaccine at all when we review what scientists hoped for a year ago. It is just the other two vaccines have set the bars too high.
- The pause is to create time for doctors around the nation to become aware of the condition and develop proper treatment. The usual treatment for blood clotting might make things worse in this particular vaccination complication.
- There might be more complication cases out there, but just a handful. It won’t be on a different magnitude.
- We might need a booster in the future depends how variants play out in the future.